• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec3
Genmab A/S Completes $2.5 Billion Bond Offering for Merus N.V. Acquisition
20:03
Dec2
Genmab and Pfizer's cervical cancer drug approved by UK regulatory body
16:53
Nov27
Genmab Plans Acquisition of Merus to Enhance Product Portfolio
23:46
Nov26
Genmab A/S amends its articles of association to enhance financial flexibility and support growth
12:37
Nov22
Wall Street Zen Upgrades Genmab A/S to Buy
08:09
Nov19
Genmab Amends Bylaws to Increase Capital and Issue Warrants
18:21

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.022 B, Net Income 401 M, EPS 0.646

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 925 M, Net Income 336 M, EPS 0.542

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 715 M, Net Income 195 M, EPS 0.305

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More